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Abstract
Objective
Muscle carnosine and its methylated form anserine are histidine-containing dipeptides.
Both dipeptides have the ability to quench reactive carbonyl species and previous studies
have shown that endogenous tissue levels are decreased in chronic diseases, such
as diabetes.
Design and Methods
Rodent study: Skeletal muscles of rats and mice were collected from 4 different diet-inter-
vention studies, aiming to induce various degrees of glucose intolerance: 45% high-fat feed-
ing (male rats), 60% high-fat feeding (male rats), cafeteria feeding (male rats), 70% high-fat
feeding (female mice). Body weight, glucose-tolerance and muscle histidine-containing di-
peptides were assessed. Human study:Muscle biopsies were taken fromm. vastus lateralis
in 35 males (9 lean, 8 obese, 9 prediabetic and 9 newly diagnosed type 2 diabetic patients)
and muscle carnosine and gene expression of muscle fiber type markers were measured.
Results
Diet interventions in rodents (cafeteria and 70% high-fat feeding) induced increases in body
weight, glucose intolerance and levels of histidine-containing dipeptides in muscle. In hu-
mans, obese, prediabetic and diabetic men had increased muscle carnosine content com-
pared to the lean (+21% (p>0.1), +30% (p<0.05) and +39% (p<0.05), respectively). The
gene expression of fast-oxidative type 2A myosin heavy chain was increased in the predia-
betic (1.8-fold, p<0.05) and tended to increase in the diabetic men (1.6-fold, p = 0.07), com-
pared to healthy lean subjects.
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Conclusion
Muscle histidine-containing dipeptides increases with progressive glucose intolerance, in
male individuals (cross-sectional). In addition, high-fat diet-induced glucose intolerance
was associated with increased muscle histidine-containing dipeptides in female mice (inter-
ventional). Increased muscle carnosine content might reflect fiber type composition and/or
act as a compensatory mechanism aimed at preventing cell damage in states of impaired
glucose tolerance.
Introduction
Histidine-containing dipeptides (HCD) are peptides consisting of a histidine (or a methylated
form of histidine) and the atypical amino acid beta-alanine [1]. HCD are predominantly and
abundantly present in skeletal muscle, but they are also measurable in other tissues such as
brain, kidney and liver, although in concentrations 10- to 1000-fold lower [1–4]. Human skele-
tal muscles only possess the HCD carnosine (beta-alanyl-L-histidine), whereas rodent muscles
contain carnosine along with its methylated variant anserine (beta-alanyl-N-π-methylhisti-
dine) [2].
Carnosine supplementation has recently been associated with a delayed progression of type
1 and 2 diabetes in rodents [5–8]. The mechanism has been attributed to its biochemical prop-
erty to quench and scavenge damaging species such as reactive oxygen species [9], metal-ions
[10], protein carbonyls [11] and reactive carbonyl species (RCS) such as 4-hydroxy-2-nonenal
(HNE) [12] and acrolein [13]. Aldini et al. (2011) was the first to report that obese Zucker rats
have higher levels of carnosine-HNE adducts in urine compared to their lean counterparts,
which points to HNE overproduction in the obese animals and confirms the role of carnosine
as an endogenous detoxifying agent of RCS such as HNE [14]. In addition, Baba et al. (2013)
confirmed the presence of carnosine-RCS conjugates (HNE and acrolein) in urine from nor-
mal, healthy, non-smoking adults and also demonstrated its existence in skeletal muscle of
C57BL/6 mice [15]. Interestingly, anserine has similar characteristics as carnosine [2], although
less extensively investigated.
Because of these scavenging characteristics, it is suggested that carnosine levels in diabetic
tissues are decreased, as it has been shown that diabetic tissues have high production of reactive
oxygen and carbonyl species [16]. Indeed, decreased carnosine and anserine levels are demon-
strated in retina, kidney and liver of obese and diabetic (type 1 and 2) rodents [4,6,7,17]. How-
ever, for skeletal muscle, contradiction exists. In rodents, there is only one paper available
which shows decreased carnosine levels in diaphragm muscle of STZ-induced diabetic rats
[18]. In humans, Gualano et al. [19] reported reduced carnosine content (-45%) in gastrocne-
mius muscle in type 2 diabetic patients, but not in soleus muscle nor in type 1 diabetic patients,
compared to control subjects matched for age, BMI, gender and diet. However, another study
[20] demonstrated an increase in carnosine content in soleus muscle in drug naive type 2 dia-
betic patients compared to non-diabetic controls.
Although evidence is scarce, a new research topic about supplementing carnosine in hu-
mans to combat age related chronic diseases i.e. diabetes and cardiovascular diseases is emerg-
ing because of its physiological and scavenging properties. Beta-alanine may be used as an
alternative [19,21,22], because it is the rate-limiting precursor for carnosine synthesis in muscle
[23]. However, given the conflicting findings in literature concerning muscle carnosine content
in a diabetic state, we investigated whether muscle carnosine content is indeed decreased in a
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diabetic state. We investigated this by feeding rodents various degrees of high-fat diets inducing
various degrees of glucose intolerance (interventional study) and by comparing muscle carno-
sine content in humans with different degrees in glucose tolerance (cross-sectional study).
Moreover, as it is known that exercise can reverse metabolic stress in skeletal muscle [24,25],
the additional effect of daily endurance training (rodent study) or physical activity (human
study), will be examined.
Materials and Methods
Study Design
Rodent study (intervention study). Skeletal muscles of rats and mice were collected from 4
different diet-intervention studies, aiming to induce various degrees of glucose intolerance.
The specifications of the animals and the diets are presented in Table 1. Shortly, rodents were
fed with a 45% high-fat diet, a 60% high-fat diet, a cafeteria diet or a 70% high-fat diet, and
they were compared with their own control group (receiving a control diet). In the HF 70%
study, an additional group was added to assess the effect of exercise, namely HF 70% diet in
combination with endurance training (12 m/min for 60 min per day, 5 days a week during 6
weeks). All rodents were housed at 22°C in a 12 h light/dark cycle and were given ad libitum ac-
cess to their water and specific diet.
In all rodent studies, body weight was recorded during the intervention study and glucose
intolerance was measured at the end of the intervention (cfr infra for the description of the glu-
cose tolerance tests). Thereafter, all animals were sacrificed by an intra-peritoneal injection of
sodium pentobarbital solution and muscles were dissected for the determination of muscle
HCD (carnosine and anserine). In the rat studies, the white gastrocnemius (GW) and the red
gastrocnemius (GR) were dissected because of a different muscle fiber type distribution [26]. In
the mouse study, the gastrocnemius was taken as a whole (GAS), because it is difficult to make
a visual distinction between the GR and GW in mice. The muscle samples were frozen in liquid
nitrogen and stored at −80°C until HCD content analysis. All rodent studies were approved by
Table 1. Rodent study: Specifications of the animals and their diets.
Energy content of the diet (% total kJ)
Study Species Strain Gender Age at sacriﬁce Intervention period Macro-nutrients CON HF/CAF
Rat studies
HF 45% Rats Wistar M 18 weeks 14 weeks Total CHO 70 36
Total fat 10 45 (mainly lard)
Total protein 20 19
HF 60% Rats Sprague-Dawley M 12 weeks 8 weeks Total CHO 70 20
Total fat 10 60 (mainly lard)
Total protein 20 20
CAF Rats Wistar M 18 weeks 12 weeks Total CHO 63 69 (mainly sugar)
Total fat 12 16
Total protein 25 15
Mouse study
HF 70% Mice C57BL/6J F 15 weeks 6 weeks Total CHO Standard chow <1
Total fat 72 (lard + corn oil)
Total protein 28
Abbreviations: M: male, F: female, CHO: carbohydrates, CON: control group, HF: high-fat group, CAF: cafeteria group.
doi:10.1371/journal.pone.0121062.t001
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the local animal Ethical Committee (the rat studies by KU Leuven: permit number P037/2010,
the mouse study by Université catholique de Louvain: permit number LA 1220548). All surgery
was performed under anesthesia (cfr. Infra) and all efforts were made to minimize suffering.
Human study (cross-sectional study). The study population consisted of 35 sedentary
non-vegetarian males with different degrees of body weight and glucose intolerance: 9 healthy
lean, 8 obese with normal glucose tolerance, 9 prediabetic (preT2D) and 9 newly diagnosed
drug naïve type 2 diabetic men (T2D). Prediabetes (impaired glucose tolerance and/or im-
paired fasting glucose) and type 2 diabetes were diagnosed by fasting glycemia or 2 hours
OGTT (oral glucose tolerance test) as defined by the American Diabetes Association 2006 [27].
Individuals were age-matched across the groups, with a mean age of 45 ± 7 yrs. The obese,
preT2D and T2D were BMI-matched across the groups. The samples of m. vastus lateralis
were obtained by the Bergstrom needle biopsy. Muscle samples were immediately frozen in liq-
uid nitrogen and stored at −80°C until gene expression and carnosine content analyses. Fasting
insulinemia was measured by IRMA (Immunotech, France). Daily free living ambulatory activ-
ity was monitored by accelerometers (Lifecorder Plus, Kenz, USA) during three consecutive
working days. Medium and high intensity ambulatory activity was defined as an activity with
the energy requirements exceeding 3-times the resting energy expenditure (>3 REE) [28].
The study was approved by the Ethics Committee of the University Hospital Bratislava, Co-
menius University Bratislava and the Ethics Committee of the Bratislava Region Office and it
conforms to the ethical guidelines of the Helsinki declaration of 1964, as revised in 2000. All
participants provided witnessed written informed consent prior entering the study.
Glucose tolerance tests
Rodent study. The intravenous glucose tolerance tests (IVGTT) in the rat studies (the HF 45%,
HF 60% and CAF-study) were performed according to Vaisy et al. (2011)[29]. Briefly, rats
were anaesthetized by an intraperitoneal injection of a ketamine-xylazine mixture and surgical-
ly prepared for the IVGTT, which involved catheter insertion into the left jugular vein. After
an overnight fast (16–18 h) a glucose solution (1g glucose.kg-1 body weight using a 30% w.v.-1
glucose solution in w.v-1 saline) was injected into the catheter of the conscious rats and blood
glucose and plasma insulin concentrations were measured at regular intervals. Total AUCglucose
and AUCinsulin were calculated using the trapezoidal rule.
The oral glucose tolerance tests (OGTT) from the mouse study is described in Deldicque et al.
(2013) [30]. Plasma glucose was determined on regular intervals following oral glucose gavage
(glucose 1 mg/g body weight), plasma insulin was only determined 30 min before and 15min
after glucose gavage. Total AUC for glucose (AUCglucose) was calculated using the
trapezoidal rule.
Quantification of muscle carnosine, anserine and total HCD
HCD (carnosine and anserine) were quantified by means of reversed-phase HPLC (high-per-
formance liquid chromatography). Skeletal muscles were dissolved in phosphate buffer (rat
studies: 1mg dw muscle/100μL PBS; mouse study: 10mg ww muscle/100 μLPBS; human study:
1mg wwmuscle/15 μL PBS) for homogenization. Muscle homogenates were deproteinized
using 35% sulfosalicylic acid (SSA) and centrifuged (5min, 14000g). 100μL of deproteinized su-
pernatant was dried under vacuum (40°C). Dried residues were resolved with 40μL of coupling
reagent: methanol/triethylamine/H2O/phenylisothiocyanate (PITC) (7/1/1/1) and allowed to
react for 20 minutes at room temperature. The samples were dried again and resolved in 100μL
of sodium acetate buffer (10mM, pH 6.4). The same method was applied to the combined stan-
dard solutions of carnosine (Flamma) and anserine (Sigma). The derivatized samples (20 μL)
Muscle HCD and Glucose Intolerance
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were chromatographed on a Waters HPLC system with ODS2 guard column (80Å, 5 μm,
4.6 mm X 10 mm), a Spherisorb C18/ODS2 column (4.6 x 150 mm, 5 μm), and UV detector
(wavelength: 210 nm). The columns were equilibrated with buffer A (10 mM sodium acetate
adjusted to pH 6.4 with 6% acetic acid) and buffer B (60% acetonitrile-40% buffer A) at a
flow rate of 0.8 ml/min at 25°C. The limit of quantification of muscle homogenates was 7 μM
(~0,7 mmol/kg DWmuscle). Total HCD are the sum of muscle carnosine and anserine.
The gene expression analysis
Gene expression analysis of muscle fiber type markers MYH1 (encoding the protein MyHC
‘myosin heavy chain’ 2X, present in fast-glycolytic muscle fibers), MYH2 (encoding the protein
MyHC 2A, present in fast-oxidative muscle fibers) and MYH7 (encoding the protein MyHC-β/
slow, present in slow-oxidative muscle fibers) was performed inm. vastus lateralis. Total RNA
from skeletal muscle was isolated using TriReagent (Molecular Research Center, Inc., USA),
purified with RNeasy mini Kit (Qiagen, USA) and DNAse treated (Qiagen, USA). Gene expres-
sion was measured by the qRT-PCR with ABI7900HT (Applied Biosystems, USA), using fol-
lowing set of primers designed with the PrimerExpress software (Applied Biosystems, USA):
MYH1 (FWD: 5´- TAA GAC CGA GGC AAA AAG GA-3´ REV: 5´- TGC ATC AGC CAA
GCT GTC-3´); MYH2 (FWD: 5´-TGT CTC ACT CCC AGG CTA CA-3´ REV: 5´- CCA AAA
ACA GCC AAT TCT GAG-3´); MYH7 (FWD: 5´-CTT CGT GCC TGA TGA CAA ACA-3´
REV: 5´- CAC GGT CAC TGT CTT GCC ATA-3´) and Maxima SYBRgreen/ROX gPCR mas-
ter mix (Fermentas Thermo Scientific, USA). B-2-microglobulin (B2m), Ribosomal protein
L13a (Rpl13a) & Hypoxanthine phosphoribosyltransferase 1 (HPRT1) were stably expressed
across the experimental groups and therefore used as the set of internal reference genes to cal-
culate dCt expression values. HPRT1 was determined with the aid of Taq-man gene expression
assay (Hs03929098_m1, Applied Biosystems, USA) while B2m (fwd: CGCTCCGTGG
CCTTAGC; rev: AATCTTTGGAGTACGCTGGATAGC) and Rpl13a (fwd: GGACCGTGC
GAGGTATGCT; rev: ATGCCGTCAAACACCTTGAGA) with the above specified set of
primers. PCR efficiency for the genes of interest and reference genes was tested and optimized
before the real time PCR experiment.
Statistics
Rodent study. To compare body weight, AUCglucose, AUCinsulin, muscle carnosine, anserine
and HCD between the HF/CAF groups (HF 45%, HF 60%, CAF or HF 70%) and their own
control group, data were analyzed by an independent t-test. To compare muscle carnosine,
anserine and HCD between the 3 groups (CON, HF 70% and HF 70%+ex) in the HF 70%
study, one-way ANOVA was performed. When a significant group effect was shown, a post
hoc LSD test was performed. The pearson correlation coefficient was calculated to explore the
relationship between muscle HCD and glucose tolerance (bloodglucose during OGTT/
IVGTT).
Human study. To compare muscle carnosine and gene expression levels between the 4
groups (lean, obese, preT2D and T2D), one-way ANOVA was performed. When a significant
group effect was shown, a post hoc LSD test was done. All correlations were evaluated by Pear-
son correlations. All analyses (human and rodent) were done with SPSS statistical software
(SPSS 20, Chicago, IL) and statistical significance was set at p< 0.05.
Muscle HCD and Glucose Intolerance
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Results
Body weight and glucose tolerance
Rodent study (Table 2). In theHF 45% study, body weight tended (p = 0.08) to be higher in
HF compared to CON, but glucose tolerance (AUCglucose and AUCinsulin) was not significantly
altered. In the 60% HF study, body weight and AUCinsulin were higher in HF (+ 12% and + 71%
respectively, p<0.05) compared to CON, and AUCglucose tended to be higher (+ 22%,
p = 0.054). In the CAF study, body weight, AUCglucose and AUCinsulin were all higher in HF
compared to CON (+ 12%, 25% and 139% respectively, p<0.05). In theHF 70% study, both
body weight and AUCglucose were higher in HF compared to CON (+ 14% and + 81% respec-
tively, p<0.05). In exercised high-fat diet mice (HF 70%+ex), body weight was normalized
back to levels of CONmice, however, AUCglucose did not decrease by exercise. Plasma insulin
in fasted state and at 15 min after the OGTT was not different between the three groups.
Human study. Body weight and BMI of the lean subjects was significantly lower compared
to the other three groups (body weight: lean: 78±10, obese: 99±21, preT2D: 103±8, T2D: 97±
12 kg; BMI: lean: 25±1, obese: 29±3, preT2D: 32±2, T2D: 31±3 kg/m2).
Muscle HCD and muscle fiber type markers
Rodent study (Table 3). In the HF 45% and HF 60% study, neither muscle carnosine, nor
anserine, nor the sum (total HCD) was altered by high-fat feeding (for both muscle types GR
and GW). Carnosine in GWmuscle correlated positively with the AUC of blood glucose during
the OGTT (r = 0.542, p<0.05) in the HF 45% study, but not in the HF 60% study or in the GR
muscle. In the CAF study, muscle anserine and total HCD had tendency to increase in GW by
Table 2. Rodent study: Degree of obesity and glucose tolerance for the 4 diet-interventions.
Study Obesity Glucose tolerance test
Delta body weight (g) End body weight (g) Total AUC for glucose Total AUC for insulin
mmol.l-1.min % increase ng.ml-1.min % increase
Rat studies
HF 45% CON (n = 8) 323 ± 32 430 ± 34 999 ± 138 463 ± 134
HF (n = 7) 377 ± 61 * 480 ± 69 $ 1038 ± 127 4 533 ± 246 15
HF 60% CON (n = 9) 334 ± 48 486 ± 57 1144 ± 186 171 ± 74
HF (n = 9) 390 ± 44 * 545 ± 47 * 1397 ± 305 $ 22 293 ± 139 * 71
CAFa CON (n = 11) 255 ± 14 490 ± 47 579 ± 29 185 ± 28
CAF (n = 11) 305 ± 10* 548 ± 55 * 721 ± 44 * 25 443 ± 39 * 139
Mouse study
HF 70%a CON (n = 8) 3.9 ± 1.0 21.6 ± 1.9 168 ± 68
HF (n = 8) 6.1 ± 1.1 * 23.1 ± 1.5 304 ± 127 * 81 not available
HF + ex (n = 6) 4.7 ± 1.3 ** 20.7 ± 1.4** 280 ± 71 * 67
Values are expressed as mean ± SD.
* p<0.05 versus CON,
** p<0.05 HF+ex versus HF and
$ p<0.1 versus CON.
Underlined % increase (compared to CON) are signiﬁcant with p<0.05.
aData from the CAF and HF 70% study are obtained from respectively Vaisy et al. (27) and Deldicque et al.(28).
Abbreviations: CON: control group, HF: high-fat group, CAF: cafeteria group, HF+ex: high-fat+exercise group.
doi:10.1371/journal.pone.0121062.t002
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14% (p = 0.085) and 12% (p = 0.076), respectively. No changes were reported for muscle carno-
sine and GR and no correlation was found between muscle carnosine and glucose tolerance. In
theHF 70% study, muscle carnosine significantly increased with 30% (p<0.05) and muscle
HCD tended to increase (+21%) in HF compared to CON (p = 0.095) (Fig. 1). Muscle anserine
followed a similar pattern, but it was not significant. Daily exercise training (HF 70%+ex)
seemed to counteract the high-fat diet-induced increase in muscle carnosine (Fig. 1), anserine
and total HCD compared to HF. Muscle carnosine (of the CON and HF mice) correlated posi-
tively with the AUC for glucose during the OGTT (r = 0.494, p = 0.052). In addition, muscle
carnosine tended to correlate with blood glucose at every time point during the OGTT (fasting:
r = 0.478, p = 0.061; after 15 min: r = 0.463, p = 0.071; after 30 min: r = 0.485, p = 0.057; after
60 min: r = 0.514, p<0.05, after 90 min: r = 0.553, p<0.05; after 120 min: r = 0.353, p = 0.18).
Anserine did not correlate with glucose intolerance in neither of the rodent studies.
Human study.Muscle carnosine gradually increased with obesity and progressive glucose
intolerance. Muscle carnosine of the obese, preT2D and T2D is higher [+21% (p>0.1), +30%
(p<0.05) and +39% (p<0.05), respectively], compared to the lean (Fig. 2). Muscle carnosine
correlated negatively with the level of medium and high intensity free living ambulatory activi-
ty as monitored by accelerometers (r = -0.41, p<0.05). The gene expression analysis of muscle
fiber type markers indicated a shift in muscle fiber type composition, with a significant increase
in fast-oxidative type 2A fibers (MYH2 mRNA) and a similar trend for fast-glycolytic type 2X
fibers (MYH1 mRNA) in muscle of prediabetic and T2D individuals compared to the healthy
lean subjects (MYH2 mRNA: obese: 1.1-fold (p>0.1), preT2D: 1.8-fold (p<0.05), T2D:
1.6-fold (p = 0.07) over lean and MYH1 mRNA: obese: 2.2-fold (p>0.1), preT2D: 2.7-fold
(p = 0.07), T2D: 2.5-fold (p>0.1) over lean). In addition, expression of MYH1 gene (marker of
the fast-glycolytic type 2X muscle fiber content) was positively associated with fasting
Table 3. Rodent study: Muscle carnosine, anserine and total histidine-containing dipeptides after the diet-intervention.
Carnosine Anserine HCD
mmol/kg DW mmol/kg DW mmol/kg DW
Study Group GW GR GW GR GW GR
Rat studies
HF 45% CON (n = 8) 19.1 ± 4.1 9.2 ± 2.1 34.6 ± 2.4 29.2 ± 7.6 53.7 ± 3.6 38.5 ± 7.8
HF (n = 7) 18.2 ± 4.0 8.3 ± 1.4 35.7 ± 6.5 29.4 ± 5.4 53.9 ± 9.3 37.7 ± 6.0
HF 60% CON (n = 9) 13.7 ± 3.6 5.9 ± 2.0 38.3 ± 4.3 25.4 ± 7.0 52.0 ± 4.9 31.3 ± 7.3
HF (n = 9) 12.8 ± 2.0 4.9 ± 2.0 37.7 ± 4.5 21.8 ± 4.4 50.5 ± 4.7 26.7 ± 4.1
CAF CON (n = 11) 9.7 ± 1.8 7.1 ± 0.9 30.4 ± 5.1 24.0 ± 4.0 40.1 ± 6.4 31.1 ± 4.9
CAF (n = 11) 10.5 ± 2.3 7.9 ± 1.3 34.6 ± 5.7$ 23.3 ± 3.1 45.1 ± 6.2$ 31.2 ± 3.9
Mouse study
GAS GAS GAS
HF 70% CON (n = 8) 5.4 ± 1.3 11.1 ± 2.4 16.4 ± 3.6
HF (n = 8) 7.0 ± 1.7 * 12.9 ± 2.5 19.9 ± 4.1 $
HF+ex (n = 6) 5.7 ± 1.1 10.7 ± 1.7 $$ 16.4 ± 2.6 $$
Values are expressed as mean ± SD.
* p< 0.05 HF versus CON,
$ p< 0.1 HF vs CON and
$$ p<0.1 HF+ex vs HF.
Abbreviations: CON: control group, HF: high-fat group, HF+ex: high-fat+exercise group, DW: dry weight, GW, GR and GAS represent the white, the red
and the gastrocnemius as a whole, respectively.
doi:10.1371/journal.pone.0121062.t003
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insulinemia (r = 0.527, p = 0.002). On the other hand, the lack of differences in MYH7 mRNA
between the 4 groups indicates that slow-oxidative type I muscle fiber content does not vary
with obesity, prediabetes or type 2 diabetes. Levels of muscle carnosine were not associated
with the variability in gene expression of muscle fiber type markers (data not shown).
Discussion
It has been suggested that carnosine levels in diabetic tissues are decreased because carnosine
can form adducts with reactive carbonyls species such as HNE and acrolein [14,15], which are
abundantly present in diabetic tissues [25]. Indeed, a decrease in carnosine content was re-
ported in retina, kidney and liver of diabetic rodents [6,7,17]. However, literature about carno-
sine levels in diabetic muscle was contradictive [18–20]. Therefore, we have now examined the
effect of different degrees of glucose intolerance on muscle HCD (carnosine and anserine) in
both rodents (intervention studies) and men (a cross-sectional study).
The current paper shows that muscle HCD content does not decrease, but instead increases
with obesity and progressive glucose intolerance in male individuals. In addition, high-fat diet-
induced glucose intolerance was associated with increased muscle HCD in female mice. The
observation that muscle tissue responds differently in a diabetic state compared to tissues such
as retina, kidney and liver, is probably related to the fact that the enzyme carnosine synthase is
considerably more expressed in skeletal muscle compared to the other tissues [31,32], whereby
restoration of initially decreased muscle carnosine levels is more easily achieved. Yet, it is possi-
ble that a compensation mechanism is activated, ultimately leading to net increased
carnosine levels.
Fig 1. Rodent study: The effect of a 70% high-fat diet on muscle carnosine in female mice.Diamonds and stripes represent individual and group
values, respectively.* p<0.05 versus CON. Abbreviations: CON: control group, HF: high-fat diet group, HF+ex: high-fat diet+exercise group.
doi:10.1371/journal.pone.0121062.g001
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In search for an alternative explanation for this unexpected finding, we looked at the known
determinants of muscle carnosine content and whether or not glucose intolerance could play
an interfering role. In addition to age and sex, muscle fiber type is one of the most important
determinants of muscle carnosine content, both in rodents and humans [33–37]. The fast type
2 muscle fibers (both the fast-glycolytic as well as the fast-oxidative muscle fibers) possess al-
most a double amount of carnosine compared to the oxidative type I muscle fibers [38]. As sev-
eral studies have shown that obesity and type 2 diabetes are associated with an increased
proportion of fast glycolytic type 2 fibers and a reduced percentage of slow type 1 fibers com-
pared with lean healthy individuals, it is plausible to speculate that a shift towards a faster fiber
type might contribute to the higher carnosine content in type 2 diabetic muscle.
There are some indications in this paper that support our fiber-type explanation. First, both
our rodent and human study demonstrated that aerobic exercise (mice) or physical activity
(human), which is known to stimulate or preserve oxidative type 1 fibers [39], counteracted the
increase in muscle carnosine. However, it can also be related to the fact that exercise prevents
the formation of reactive carbonyl species in skeletal muscle [25], whereby the compensation
mechanism to increase muscle carnosine will not be activated. Second, a tendency towards in-
creased gene expression of MYH1 (encoding the protein myosin heavy chain 2X, present in
fast-glycolytic type 2 fibers) and MYH2 (encoding the protein myosin heavy chain 2A, present
in fast-oxidative type 2 fibers) in individuals with prediabetes or type 2 diabetes suggests a
higher proportion of more fast muscle fibers (fast-glycolytic and fast-oxidative) in patients
with metabolic disease. Third, the fact that the increase in muscle HCD was only clearly present
in mice receiving the extreme 70% high-fat diet, and not in the rats receiving a 45–60% high-
Fig 2. Human study: Muscle carnosine content in lean, obese, prediabetic and diabetic type 2 patients. Values are expressed as mean ± SD.
* p<0.05 versus lean. ANOVA p-value: 0.038. Abbreviations: preT2D: prediabetic patients, T2D: diabetic type 2 patients.
doi:10.1371/journal.pone.0121062.g002
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fat diet or a cafeteria diet, is perhaps due to the fact that fiber type proportions can change
throughout the diet intervention. In the beginning of a high-fat diet intervention, muscle fiber
type changes in favor of the oxidative metabolism, including increased type I fibers, in an at-
tempt to remove lipid overload. On the other hand, towards the end of the diet, when glucose
intolerance increases, the percentage of fast-glycolytic type 2 fibers increases [40].
But why did Gualano et al. (2012) found a decrease in muscle carnosine in Brazilian T2D
patients? Compared to the younger, newly diagnosed drug naïve male T2D subjects in this
study, the Brazilian diabetic group is represented by both older (± 60 years) males and females,
with longer duration of the disease (± 7 years), receiving oral antidiabetic pharmacotherapy
(metformin and/or sulfonylurea). In both studies, patients with micro- and macrovascular
complications were excluded. It can be speculated that the compensation mechanism, which is
responsible for the initial increase in muscle carnosine, is exhausted by the longer duration of
the disease and older age. In other words, it can be expected that carnosine would be largely
used to scavenge reactive carbonyl species in the older diabetic muscle, resulting in a net de-
crease in muscle carnosine content as compared to muscles of younger, drug-naïve newly diag-
nosed diabetic patients.
Finally, in this work, we demonstrated that muscle HCD content increases with obesity and
progressive glucose intolerance inmale subjects. So, it can be questioned whether this observa-
tion would also occur in females. We cannot ignore that the carnosine metabolism is partly
gender dependent. Muscle carnosine storage and serum carnosinase (the enzyme that hydroly-
ses carnosine) is respectively lower and higher in women than in men [41,42]. However, deter-
minants of muscle carnosine storage (such as age and fiber type) and muscle carnosine loading
(by beta-alanine supplementation) are gender independent [34,43]. In addition, a 70% high-fat
diet increased muscle carnosine in femalemice. We suggest we can extrapolate this to female
humans. Although rodents do not have the enzyme serum carnosinase and although they pos-
sess next to carnosine also the methylated variant anserine, it has previously been shown that
muscle HCD storage in rodents and humans is quite similar. Both species share the similar de-
terminants of muscle HCD content (age, sex, fiber type, beta-alanine supplementation)[23,33–
37].
Both an increase and decrease in muscle carnosine (or anserine) with prediabetes or type 2
diabetes were reported in existing literature [19,20]. However, our results demonstrate a gradu-
al increase in muscle HCD with progressive glucose intolerance in male individuals. In addi-
tion, high-fat diet-induced glucose intolerance is associated with increased muscle HCD in
female mice. We underscore the importance of future studies aiming to better understand the
metabolic pathways and the (patho)physiological significance of HCD in muscle in particular
and in the body in general, in order to optimally design therapeutic strategies interfering with
the carnosine system in metabolic diseases.
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